Repurposing food molecules as a potential BACE1 inhibitor for Alzheimer’s disease

Author:

Mukerjee Nobendu,Das Anubhab,Jawarkar Rahul D.,Maitra Swastika,Das Padmashree,Castrosanto Melvin A.,Paul Soumyadip,Samad Abdul,Zaki Magdi E. A.,Al-Hussain Sami A.,Masand Vijay H.,Hasan Mohammad Mehedi,Bukhari Syed Nasir Abbas,Perveen Asma,Alghamdi Badrah S.,Alexiou Athanasios,Kamal Mohammad Amjad,Dey Abhijit,Malik Sumira,Bakal Ravindra L.,Abuzenadah Adel Mohammad,Ghosh Arabinda,Md Ashraf Ghulam

Abstract

Alzheimer’s disease (AD) is a severe neurodegenerative disorder of the brain that manifests as dementia, disorientation, difficulty in speech, and progressive cognitive and behavioral impairment. The emerging therapeutic approach to AD management is the inhibition of β-site APP cleaving enzyme-1 (BACE1), known to be one of the two aspartyl proteases that cleave β-amyloid precursor protein (APP). Studies confirmed the association of high BACE1 activity with the proficiency in the formation of β-amyloid-containing neurotic plaques, the characteristics of AD. Only a few FDA-approved BACE1 inhibitors are available in the market, but their adverse off-target effects limit their usage. In this paper, we have used both ligand-based and target-based approaches for drug design. The QSAR study entails creating a multivariate GA-MLR (Genetic Algorithm-Multilinear Regression) model using 552 molecules with acceptable statistical performance (R2 = 0.82, Q2loo = 0.81). According to the QSAR study, the activity has a strong link with various atoms such as aromatic carbons and ring Sulfur, acceptor atoms, sp2-hybridized oxygen, etc. Following that, a database of 26,467 food compounds was primarily used for QSAR-based virtual screening accompanied by the application of the Lipinski rule of five; the elimination of duplicates, salts, and metal derivatives resulted in a truncated dataset of 8,453 molecules. The molecular descriptor was calculated and a well-validated 6-parametric version of the QSAR model was used to predict the bioactivity of the 8,453 food compounds. Following this, the food compounds whose predicted activity (pKi) was observed above 7.0 M were further docked into the BACE1 receptor which gave rise to the Identification of 4-(3,4-Dihydroxyphenyl)-2-hydroxy-1H-phenalen-1-one (PubChem I.D: 4468; Food I.D: FDB017657) as a hit molecule (Binding Affinity = −8.9 kcal/mol, pKi = 7.97 nM, Ki = 10.715 M). Furthermore, molecular dynamics simulation for 150 ns and molecular mechanics generalized born and surface area (MMGBSA) study aided in identifying structural motifs involved in interactions with the BACE1 enzyme. Molecular docking and QSAR yielded complementary and congruent results. The validated analyses can be used to improve a drug/lead candidate’s inhibitory efficacy against the BACE1. Thus, our approach is expected to widen the field of study of repurposing nutraceuticals into neuroprotective as well as anti-cancer and anti-viral therapeutic interventions.

Funder

Imam Mohammed Ibn Saud Islamic University

Publisher

Frontiers Media SA

Subject

Cognitive Neuroscience,Aging

Reference60 articles.

1. 2012 Alzheimer’s disease facts and figures.;Alzheimer’s Dement.,2012

2. In silico inhibition of BACE-1 by selective phytochemicals as novel potential inhibitors: Molecular docking and DFT studies.;Arif;Curr. Drug Disc. Technol.,2020

3. and ROS1 as a joint target for the treatment of lung cancer: A review.;Bellacasa;Transl. Lung Cancer Res.,2013

4. The protein data bank.;Berman;Nucleic Acids Res.,2000

5. Chemical constituents from Musella lasiocarpa (Franch.) CY Wu.;Bo;Nat. Product Res. Develop.,2000

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3